Widschwendter M et al. |
Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers. |
2015 |
EBioMedicine |
pmid:26629528
|
Silva Vde O et al. |
β-Glucans (Saccharomyces cereviseae) Reduce Glucose Levels and Attenuate Alveolar Bone Loss in Diabetic Rats with Periodontal Disease. |
2015 |
PLoS ONE |
pmid:26291983
|
Darabi H et al. |
Adiponectin as a Protective Factor Against the Progression Toward Type 2 Diabetes Mellitus in Postmenopausal Women. |
2015 |
Medicine (Baltimore) |
pmid:26287420
|
Kastritis E et al. |
Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging. |
2015 |
Blood Cancer J |
pmid:26047389
|
Janda K et al. |
Cardiovascular risk in chronic kidney disease patients: intima-media thickness predicts the incidence and severity of histologically assessed medial calcification in radial arteries. |
2015 |
BMC Nephrol |
pmid:26037625
|
Zhao L et al. |
Effects of dietary resveratrol on excess-iron-induced bone loss via antioxidative character. |
2015 |
J. Nutr. Biochem. |
pmid:26239832
|
Qiao B et al. |
Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma. |
2015 |
Drug Des Devel Ther |
pmid:25733814
|
Choe CH et al. |
Transmembrane protein 173 inhibits RANKL-induced osteoclast differentiation. |
2015 |
FEBS Lett. |
pmid:25728277
|
de Molon RS et al. |
OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice. |
2015 |
J. Bone Miner. Res. |
pmid:25727550
|
Lee CJ et al. |
Serum osteoprotegerin is associated with arterial stiffness assessed according to the cardio-ankle vascular index in hypertensive patients. |
2015 |
J. Atheroscler. Thromb. |
pmid:25318352
|